Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications
18 nov. 2024 10h48 HE
|
Spark Biomedical
Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...
Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI-Algorithm for Opioid Withdrawal and Cravings Detection
12 sept. 2024 13h39 HE
|
Spark Biomedical
Dallas, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, is partnering with prestigious research and behavioral health institutes, Battelle...
Turning Point of Tampa’s Dr. Hardeep Singh Recognized in Tampa Magazine’s TOP Doctors List for Third Consecutive Year
06 août 2024 09h00 HE
|
Turning Point of Tampa
Tampa, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Turning Point of Tampa is proud to announce that Dr. Hardeep Singh, our esteemed Medical Director, has been named to Tampa Magazine’s TOP Doctors List...
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
09 janv. 2024 08h30 HE
|
BioCorRx Inc
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
18 juil. 2023 08h30 HE
|
BioCorRx Inc
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
Drug Testing Market Size to Cross USD 15.7 Bn by 2033 with CAGR of 5.3% | Transparency Market Research
20 mars 2023 11h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 20, 2023 (GLOBE NEWSWIRE) -- According to the latest research by Transparency Market Research, the drug testing market was estimated to attain a global...
BioCorRx Attended 4th Annual NIH HEAL Initiative Investigator Meeting; Shares Update on BICX104 Data
23 févr. 2023 08h30 HE
|
BioCorRx Inc
ANAHEIM, CA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related...
Turning Point of Tampa Opens Drug and Alcohol Detoxification Program
12 août 2022 09h00 HE
|
Turning Point of Tampa
Tampa, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Turning Point of Tampa, a leading treatment provider in Tampa, Florida is pleased to announce the expansion of services to include medical detoxification...
X Waiver Mini-Course Expands Emergency Clinician Recognition and Treatment of Opioid Withdrawal, Study Finds
13 avr. 2022 08h00 HE
|
American College of Medical Toxicology
Phoenix, AZ, April 13, 2022 (GLOBE NEWSWIRE) -- “A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)” was a study funded by a grant to the...
American College of Medical Toxicology Presents 2022 Virtual Annual Scientific Meeting & Symposium
25 janv. 2022 09h55 HE
|
American College of Medical Toxicology
Phoenix, AZ, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology (ACMT) 2022 Annual Scientific Meeting (ASM) will be held virtually from Friday, March 11 through Sunday,...